(LYV) Live Nation Entertainment - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US5380341090
Stock: Concerts, Ticketing, Sponsorship
Total Rating 54
Risk 62
Buy Signal -0.03
| Risk 5d forecast | |
|---|---|
| Volatility | 28.6% |
| Relative Tail Risk | -6.41% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.96 |
| Alpha | 8.58 |
| Character TTM | |
|---|---|
| Beta | 1.153 |
| Beta Downside | 1.815 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.84% |
| CAGR/Max DD | 1.26 |
EPS (Earnings per Share)
Revenue
Description: LYV Live Nation Entertainment March 04, 2026
Live Nation Entertainment Inc. (LYV) operates in the live entertainment sector, primarily through three segments: Concerts, Ticketing, and Sponsorship & Advertising.
The Concerts segment promotes live music events, manages venues, produces festivals, and provides artist services. This business model relies on attracting audiences to physical events.
The Ticketing segment manages ticket sales for a variety of events, including concerts, sports, and performing arts. This segment provides software and services to venues and consumers, a common practice in event management.
The Sponsorship & Advertising segment sells advertising and sponsorship placements across its venues, events, and digital platforms. This segment leverages event attendance and audience demographics to generate revenue.
For more detailed financial analysis, ValueRay offers comprehensive company profiles.
Headlines to watch out for
- Concert attendance drives revenue growth
- Ticketmaster fees face regulatory scrutiny
- Sponsorship deals boost advertising income
- Venue operating costs impact profitability
- Economic downturns reduce consumer entertainment spending
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 496.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -3.89 > 1.0 |
| NWC/Revenue: -0.22% < 20% (prev -0.29%; Δ 0.08% < -1%) |
| CFO/TA 0.06 > 3% & CFO 1.40b > Net Income 496.0m |
| Net Debt (5.33b) to EBITDA (2.01b): 2.65 < 3 |
| Current Ratio: 1.00 > 1.5 & < 3 |
| Outstanding Shares: last quarter (235.4m) vs 12m ago -0.39% < -2% |
| Gross Margin: 45.40% > 18% (prev 0.25%; Δ 4515 % > 0.5%) |
| Asset Turnover: 118.5% > 50% (prev 117.9%; Δ 0.54% > 0%) |
| Interest Coverage Ratio: 4.26 > 6 (EBITDA TTM 2.01b / Interest Expense TTM 316.0m) |
Altman Z'' 0.20
| A: -0.00 (Total Current Assets 10.97b - Total Current Liabilities 11.03b) / Total Assets 22.91b |
| B: -0.05 (Retained Earnings -1.04b / Total Assets 22.91b) |
| C: 0.06 (EBIT TTM 1.35b / Avg Total Assets 21.28b) |
| D: -0.05 (Book Value of Equity -1.15b / Total Liabilities 21.09b) |
| Altman-Z'' Score: 0.20 = B |
Beneish M -3.38
| DSRI: 1.09 (Receivables 2.08b/1.75b, Revenue 25.20b/23.16b) |
| GMI: 0.55 (GM 45.40% / 25.17%) |
| AQI: 0.91 (AQ_t 0.29 / AQ_t-1 0.32) |
| SGI: 1.09 (Revenue 25.20b / 23.16b) |
| TATA: -0.04 (NI 496.0m - CFO 1.40b) / TA 22.91b) |
| Beneish M-Score: -3.38 (Cap -4..+1) = AA |
What is the price of LYV shares?
As of March 11, 2026, the stock is trading at USD 165.53 with a total of 2,508,435 shares traded.
Over the past week, the price has changed by +2.13%, over one month by +10.86%, over three months by +19.24% and over the past year by +34.81%.
Over the past week, the price has changed by +2.13%, over one month by +10.86%, over three months by +19.24% and over the past year by +34.81%.
Is LYV a buy, sell or hold?
Live Nation Entertainment has received a consensus analysts rating of 4.39.
Therefore, it is recommended to buy LYV.
- StrongBuy: 15
- Buy: 4
- Hold: 3
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the LYV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 183.7 | 11% |
| Analysts Target Price | 183.7 | 11% |
LYV Fundamental Data Overview March 11, 2026
P/E Forward = 196.0784
P/S = 1.5448
P/B = 135.2719
P/EG = 7.1488
Revenue TTM = 25.20b USD
EBIT TTM = 1.35b USD
EBITDA TTM = 2.01b USD
Long Term Debt = 7.61b USD (from longTermDebt, last quarter)
Short Term Debt = 755.4m USD (from shortTermDebt, last quarter)
Debt = 12.44b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.33b USD (from netDebt column, last quarter)
Enterprise Value = 44.28b USD (38.93b + Debt 12.44b - CCE 7.09b)
Interest Coverage Ratio = 4.26 (Ebit TTM 1.35b / Interest Expense TTM 316.0m)
EV/FCF = 132.7x (Enterprise Value 44.28b / FCF TTM 333.6m)
FCF Yield = 0.75% (FCF TTM 333.6m / Enterprise Value 44.28b)
FCF Margin = 1.32% (FCF TTM 333.6m / Revenue TTM 25.20b)
Net Margin = 1.97% (Net Income TTM 496.0m / Revenue TTM 25.20b)
Gross Margin = 45.40% ((Revenue TTM 25.20b - Cost of Revenue TTM 13.76b) / Revenue TTM)
Gross Margin QoQ = 20.41% (prev 85.07%)
Tobins Q-Ratio = 1.93 (Enterprise Value 44.28b / Total Assets 22.91b)
Interest Expense / Debt = 0.67% (Interest Expense 83.4m / Debt 12.44b)
Taxrate = 32.97% (339.8m / 1.03b)
NOPAT = 902.6m (EBIT 1.35b * (1 - 32.97%))
Current Ratio = 1.00 (Total Current Assets 10.97b / Total Current Liabilities 11.03b)
Debt / Equity = 45.91 (Debt 12.44b / totalStockholderEquity, last quarter 271.0m)
Debt / EBITDA = 2.65 (Net Debt 5.33b / EBITDA 2.01b)
Debt / FCF = 15.99 (Net Debt 5.33b / FCF TTM 333.6m)
Total Stockholder Equity = 314.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.33% (Net Income 496.0m / Total Assets 22.91b)
RoE = 157.7% (Net Income TTM 496.0m / Total Stockholder Equity 314.6m)
RoCE = 16.99% (EBIT 1.35b / Capital Employed (Equity 314.6m + L.T.Debt 7.61b))
RoIC = 12.16% (NOPAT 902.6m / Invested Capital 7.43b)
WACC = 7.81% (E(38.93b)/V(51.37b) * Re(10.16%) + D(12.44b)/V(51.37b) * Rd(0.67%) * (1-Tc(0.33)))
Discount Rate = 10.16% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.45%
[DCF] Terminal Value 73.45% ; FCFF base≈620.2m ; Y1≈454.0m ; Y5≈257.7m
[DCF] Fair Price = N/A (negative equity: EV 5.05b - Net Debt 5.33b = -284.2m; debt exceeds intrinsic value)
EPS Correlation: 2.76 | EPS CAGR: -27.59% | SUE: -0.08 | # QB: 0
Revenue Correlation: 52.76 | Revenue CAGR: 39.69% | SUE: 0.45 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.00 | Chg7d=+0.002 | Chg30d=-0.057 | Revisions Net=-4 | Analysts=12
EPS current Year (2026-12-31): EPS=1.50 | Chg7d=-0.005 | Chg30d=-0.447 | Revisions Net=-6 | Growth EPS=+723.4% | Growth Revenue=+9.1%
EPS next Year (2027-12-31): EPS=2.27 | Chg7d=-0.003 | Chg30d=-0.650 | Revisions Net=-8 | Growth EPS=+51.6% | Growth Revenue=+9.3%
[Analyst] Revisions Ratio: -1.00 (0 Up / 4 Down within 30d for Next Quarter)
P/S = 1.5448
P/B = 135.2719
P/EG = 7.1488
Revenue TTM = 25.20b USD
EBIT TTM = 1.35b USD
EBITDA TTM = 2.01b USD
Long Term Debt = 7.61b USD (from longTermDebt, last quarter)
Short Term Debt = 755.4m USD (from shortTermDebt, last quarter)
Debt = 12.44b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.33b USD (from netDebt column, last quarter)
Enterprise Value = 44.28b USD (38.93b + Debt 12.44b - CCE 7.09b)
Interest Coverage Ratio = 4.26 (Ebit TTM 1.35b / Interest Expense TTM 316.0m)
EV/FCF = 132.7x (Enterprise Value 44.28b / FCF TTM 333.6m)
FCF Yield = 0.75% (FCF TTM 333.6m / Enterprise Value 44.28b)
FCF Margin = 1.32% (FCF TTM 333.6m / Revenue TTM 25.20b)
Net Margin = 1.97% (Net Income TTM 496.0m / Revenue TTM 25.20b)
Gross Margin = 45.40% ((Revenue TTM 25.20b - Cost of Revenue TTM 13.76b) / Revenue TTM)
Gross Margin QoQ = 20.41% (prev 85.07%)
Tobins Q-Ratio = 1.93 (Enterprise Value 44.28b / Total Assets 22.91b)
Interest Expense / Debt = 0.67% (Interest Expense 83.4m / Debt 12.44b)
Taxrate = 32.97% (339.8m / 1.03b)
NOPAT = 902.6m (EBIT 1.35b * (1 - 32.97%))
Current Ratio = 1.00 (Total Current Assets 10.97b / Total Current Liabilities 11.03b)
Debt / Equity = 45.91 (Debt 12.44b / totalStockholderEquity, last quarter 271.0m)
Debt / EBITDA = 2.65 (Net Debt 5.33b / EBITDA 2.01b)
Debt / FCF = 15.99 (Net Debt 5.33b / FCF TTM 333.6m)
Total Stockholder Equity = 314.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.33% (Net Income 496.0m / Total Assets 22.91b)
RoE = 157.7% (Net Income TTM 496.0m / Total Stockholder Equity 314.6m)
RoCE = 16.99% (EBIT 1.35b / Capital Employed (Equity 314.6m + L.T.Debt 7.61b))
RoIC = 12.16% (NOPAT 902.6m / Invested Capital 7.43b)
WACC = 7.81% (E(38.93b)/V(51.37b) * Re(10.16%) + D(12.44b)/V(51.37b) * Rd(0.67%) * (1-Tc(0.33)))
Discount Rate = 10.16% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.45%
[DCF] Terminal Value 73.45% ; FCFF base≈620.2m ; Y1≈454.0m ; Y5≈257.7m
[DCF] Fair Price = N/A (negative equity: EV 5.05b - Net Debt 5.33b = -284.2m; debt exceeds intrinsic value)
EPS Correlation: 2.76 | EPS CAGR: -27.59% | SUE: -0.08 | # QB: 0
Revenue Correlation: 52.76 | Revenue CAGR: 39.69% | SUE: 0.45 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.00 | Chg7d=+0.002 | Chg30d=-0.057 | Revisions Net=-4 | Analysts=12
EPS current Year (2026-12-31): EPS=1.50 | Chg7d=-0.005 | Chg30d=-0.447 | Revisions Net=-6 | Growth EPS=+723.4% | Growth Revenue=+9.1%
EPS next Year (2027-12-31): EPS=2.27 | Chg7d=-0.003 | Chg30d=-0.650 | Revisions Net=-8 | Growth EPS=+51.6% | Growth Revenue=+9.3%
[Analyst] Revisions Ratio: -1.00 (0 Up / 4 Down within 30d for Next Quarter)